Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $13
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $12 to $13.
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $12 to $13.